Investors · healthtech · AI in healthcare

AI in healthcare, B2B2C SaaS: proven B2C demand, a B2B2C channel opening up, a bootstrapped company.

A French healthtech start-up specialising in AI for healthcare, Smart Medical Care has been funded by its founders and by physicians from its committee. This page summarises the thesis; the full deck, accounts and data room are shared on request.

The investment thesis

100% organic acquisition

100% organic acquisition, with no ad spend, in more than 40 languages. Every new language opens a market.

A clinical layer that is hard to replicate

Three years of feedback from 13 physicians, turned into AI framing. The language model is interchangeable; the layer is not.

Aligned interests with laboratories

The laboratory already holds the patient's attention and trust at the moment of the result. The revenue share brings it additional revenue with no investment and no advertising, which it is not allowed to do.

Traction

100+customer countries
40+languages available
13physicians on the scientific and ethics committee
98 %find the report clear
8.9/10average satisfaction
91 %ready to recommend the report

Customer survey of 30 October 2026, 249 responses. Figures as of 30 October 2026.

Business model: B2B2C and B2C SaaS

B2C

Single report and annual patient-portal subscription, across several brands and in more than 40 languages.

B2B2C

White label, API or co-branded pathway for laboratories, clinics, insurers and pharmacies: revenue share with the partner, country licensing for distributors.

Celya

Marketplace for prescription-free check-ups, in development: Celya will acquire the patient, collect payment, and buy the panel from the partner laboratory. An additional distribution channel for laboratories.

Roadmap

  1. Short term

    360° patient portal: lab tests, nutrition, psychological tests, profile and family space, with a switch to a recurring (subscription) model. AI interpretation of psychological tests. First laboratory contracts.

  2. Medium term

    Connected devices in the portal. Celya launch in France with partner laboratories. Pets in the family space with AI DiagAnimals.

  3. Long term

    Imaging, DNA and microbiome in the AI cross-referencing, for a 360° view of each person's and family's health, alongside partner laboratories.

A demo on a real lab report

We generate a report on a real lab result, in your language, then work out with you the integration and business model suited to your organisation.